Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01464606 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 21, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Dec 2022 to Dec 2025
    • Study completion date: Dec 2024 to Dec 2028
    v11
  2. Notable Primary completion date: Dec 2021 to Dec 2022
    • Study completion date: Dec 2021 to Dec 2024
    • Study site revised
    v10
  3. Notable Primary and study completion dates: Dec 2019 to Dec 2021v9 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 125 to confirmed 156
    • Start date: Sep 2011 to Dec 22, 2009
    • Site details revised
  4. Minor Eligibility criteria expanded, about 53 words
    • Site contact updated
    v8
  5. Minor Eligibility criteria expanded, about 30 wordsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Primary completion date: Sep 2016 to Dec 2019
    • Study completion date: Sep 2018 to Dec 2019
    v6
  2. Minor Site contact updated
    • Study description expanded, about 1 word
    v5
  3. Minor 3 versions Re-verified since Jun 14, 2012, no change to tracked fieldsv2-v4
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pleuropulmonary Blastoma (PPB) is very rare and there is no established "standard" or "best" therapy. For many years, children with PPB around the world have been treated according to decisions made case-by-case in many different hospitals by many different physicians. No treatment has been tested in a large group of PPB patients. The goal is to treat many children with one treatment program and to learn the results of the treatment.
Trial Details
NCT Number NCT01464606
Lead Sponsor Children's Hospitals and Clinics of Minnesota
Conditions
(from sponsor)
Pleuropulmonary Blastoma
Related terms Cystic Disease Of Lung, Pleuropulmonary blastoma
Enrollment 156 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov